CN106166123B - 具有抗敏止痒功效的护肤组合物、乳液及其制备方法 - Google Patents
具有抗敏止痒功效的护肤组合物、乳液及其制备方法 Download PDFInfo
- Publication number
- CN106166123B CN106166123B CN201610640817.4A CN201610640817A CN106166123B CN 106166123 B CN106166123 B CN 106166123B CN 201610640817 A CN201610640817 A CN 201610640817A CN 106166123 B CN106166123 B CN 106166123B
- Authority
- CN
- China
- Prior art keywords
- phase
- skin care
- stirring
- raw materials
- ethanol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 30
- 208000003251 Pruritus Diseases 0.000 title claims abstract description 24
- 230000003266 anti-allergic effect Effects 0.000 title claims abstract description 18
- 238000002360 preparation method Methods 0.000 title claims description 24
- 239000006210 lotion Substances 0.000 title 1
- 230000000694 effects Effects 0.000 claims abstract description 31
- 239000000284 extract Substances 0.000 claims abstract description 20
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims abstract description 18
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 13
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 claims abstract description 12
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 claims abstract description 11
- 229920001285 xanthan gum Polymers 0.000 claims abstract description 11
- 241000168517 Haematococcus lacustris Species 0.000 claims abstract description 8
- 241000830535 Ligustrum lucidum Species 0.000 claims abstract description 8
- 235000011034 Rubus glaucus Nutrition 0.000 claims abstract description 8
- 235000009122 Rubus idaeus Nutrition 0.000 claims abstract description 8
- 240000007651 Rubus glaucus Species 0.000 claims abstract description 7
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 claims abstract description 6
- 244000062241 Kaempferia galanga Species 0.000 claims abstract description 6
- 229960000458 allantoin Drugs 0.000 claims abstract description 6
- 229960003966 nicotinamide Drugs 0.000 claims abstract description 6
- 235000005152 nicotinamide Nutrition 0.000 claims abstract description 6
- 239000011570 nicotinamide Substances 0.000 claims abstract description 6
- 239000000230 xanthan gum Substances 0.000 claims abstract description 6
- 229940082509 xanthan gum Drugs 0.000 claims abstract description 6
- 235000010493 xanthan gum Nutrition 0.000 claims abstract description 6
- 230000001139 anti-pruritic effect Effects 0.000 claims abstract description 4
- 239000003755 preservative agent Substances 0.000 claims abstract description 3
- 230000002335 preservative effect Effects 0.000 claims abstract description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 52
- 239000002994 raw material Substances 0.000 claims description 44
- 238000003756 stirring Methods 0.000 claims description 33
- 239000003814 drug Substances 0.000 claims description 31
- 238000010438 heat treatment Methods 0.000 claims description 23
- 239000000839 emulsion Substances 0.000 claims description 20
- 238000002156 mixing Methods 0.000 claims description 18
- 238000001816 cooling Methods 0.000 claims description 15
- 239000000706 filtrate Substances 0.000 claims description 15
- 238000000034 method Methods 0.000 claims description 12
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 claims description 10
- 239000012141 concentrate Substances 0.000 claims description 10
- 238000004321 preservation Methods 0.000 claims description 10
- 238000005303 weighing Methods 0.000 claims description 10
- 229940079593 drug Drugs 0.000 claims description 8
- 238000001914 filtration Methods 0.000 claims description 8
- 241000167854 Bourreria succulenta Species 0.000 claims description 6
- 235000019693 cherries Nutrition 0.000 claims description 6
- 238000003828 vacuum filtration Methods 0.000 claims description 6
- LXAHHHIGZXPRKQ-UHFFFAOYSA-N 5-fluoro-2-methylpyridine Chemical compound CC1=CC=C(F)C=N1 LXAHHHIGZXPRKQ-UHFFFAOYSA-N 0.000 claims description 5
- GJCOSYZMQJWQCA-UHFFFAOYSA-N 9H-xanthene Chemical compound C1=CC=C2CC3=CC=CC=C3OC2=C1 GJCOSYZMQJWQCA-UHFFFAOYSA-N 0.000 claims description 5
- 235000013421 Kaempferia galanga Nutrition 0.000 claims description 5
- 235000019437 butane-1,3-diol Nutrition 0.000 claims description 5
- 238000007599 discharging Methods 0.000 claims description 5
- 239000012676 herbal extract Substances 0.000 claims description 5
- 238000002390 rotary evaporation Methods 0.000 claims description 5
- 239000008280 blood Substances 0.000 abstract description 20
- 210000004369 blood Anatomy 0.000 abstract description 20
- 244000141698 Prunus lannesiana Species 0.000 abstract description 7
- 235000014001 Prunus serrulata Nutrition 0.000 abstract description 7
- 239000000463 material Substances 0.000 abstract description 6
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 abstract 1
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
- CKQVRZJOMJRTOY-UHFFFAOYSA-N octadecanoic acid;propane-1,2,3-triol Chemical compound OCC(O)CO.CCCCCCCCCCCCCCCCCC(O)=O CKQVRZJOMJRTOY-UHFFFAOYSA-N 0.000 abstract 1
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 abstract 1
- 229940100460 peg-100 stearate Drugs 0.000 abstract 1
- 229920005573 silicon-containing polymer Polymers 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
- UEUXEKPTXMALOB-UHFFFAOYSA-J tetrasodium;2-[2-[bis(carboxylatomethyl)amino]ethyl-(carboxylatomethyl)amino]acetate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]C(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O UEUXEKPTXMALOB-UHFFFAOYSA-J 0.000 abstract 1
- 229940042585 tocopherol acetate Drugs 0.000 abstract 1
- LADGBHLMCUINGV-UHFFFAOYSA-N tricaprin Chemical compound CCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCC)COC(=O)CCCCCCCCC LADGBHLMCUINGV-UHFFFAOYSA-N 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 description 35
- 239000000243 solution Substances 0.000 description 16
- 238000002474 experimental method Methods 0.000 description 15
- 108010003272 Hyaluronate lyase Proteins 0.000 description 12
- 102000001974 Hyaluronidases Human genes 0.000 description 12
- 230000001815 facial effect Effects 0.000 description 12
- 229960002773 hyaluronidase Drugs 0.000 description 12
- 230000005764 inhibitory process Effects 0.000 description 10
- 230000007803 itching Effects 0.000 description 9
- 208000024891 symptom Diseases 0.000 description 9
- 239000000047 product Substances 0.000 description 7
- 239000000523 sample Substances 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- 238000000605 extraction Methods 0.000 description 6
- 229960001660 histamine phosphate Drugs 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- 206010020751 Hypersensitivity Diseases 0.000 description 5
- 208000026935 allergic disease Diseases 0.000 description 5
- 230000007815 allergy Effects 0.000 description 5
- ZHIBQGJKHVBLJJ-UHFFFAOYSA-N histamine phosphate Chemical compound OP(O)(O)=O.OP(O)(O)=O.NCCC1=CNC=N1 ZHIBQGJKHVBLJJ-UHFFFAOYSA-N 0.000 description 5
- 230000002829 reductive effect Effects 0.000 description 5
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 4
- 241000700199 Cavia porcellus Species 0.000 description 4
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 4
- YRKCREAYFQTBPV-UHFFFAOYSA-N acetylacetone Chemical compound CC(=O)CC(C)=O YRKCREAYFQTBPV-UHFFFAOYSA-N 0.000 description 4
- 229920002674 hyaluronan Polymers 0.000 description 4
- 229960003160 hyaluronic acid Drugs 0.000 description 4
- 230000002401 inhibitory effect Effects 0.000 description 4
- 210000003734 kidney Anatomy 0.000 description 4
- 210000004185 liver Anatomy 0.000 description 4
- 238000005259 measurement Methods 0.000 description 4
- 230000037311 normal skin Effects 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 241000700198 Cavia Species 0.000 description 3
- 241000168525 Haematococcus Species 0.000 description 3
- OVRNDRQMDRJTHS-FMDGEEDCSA-N N-acetyl-beta-D-glucosamine Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-FMDGEEDCSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 239000002537 cosmetic Substances 0.000 description 3
- 230000004438 eyesight Effects 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 210000000548 hind-foot Anatomy 0.000 description 3
- 239000012488 sample solution Substances 0.000 description 3
- 210000000434 stratum corneum Anatomy 0.000 description 3
- 201000004624 Dermatitis Diseases 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 210000001142 back Anatomy 0.000 description 2
- 239000012490 blank solution Substances 0.000 description 2
- 239000007853 buffer solution Substances 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 229940088598 enzyme Drugs 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 229960001340 histamine Drugs 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 230000001965 increasing effect Effects 0.000 description 2
- 230000004089 microcirculation Effects 0.000 description 2
- 230000027939 micturition Effects 0.000 description 2
- 239000013641 positive control Substances 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- BGNGWHSBYQYVRX-UHFFFAOYSA-N 4-(dimethylamino)benzaldehyde Chemical compound CN(C)C1=CC=C(C=O)C=C1 BGNGWHSBYQYVRX-UHFFFAOYSA-N 0.000 description 1
- 206010002198 Anaphylactic reaction Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- 240000002943 Elettaria cardamomum Species 0.000 description 1
- 208000008967 Enuresis Diseases 0.000 description 1
- BIVBRWYINDPWKA-VLQRKCJKSA-L Glycyrrhizinate dipotassium Chemical compound [K+].[K+].O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C([O-])=O)[C@@H]1O[C@H](C([O-])=O)[C@@H](O)[C@H](O)[C@H]1O BIVBRWYINDPWKA-VLQRKCJKSA-L 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010059013 Nocturnal emission Diseases 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 244000235659 Rubus idaeus Species 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- 229920002385 Sodium hyaluronate Polymers 0.000 description 1
- 206010041497 Spermatorrhoea Diseases 0.000 description 1
- 206010043189 Telangiectasia Diseases 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 239000008351 acetate buffer Substances 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 238000003916 acid precipitation Methods 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- AEMOLEFTQBMNLQ-WAXACMCWSA-N alpha-D-glucuronic acid Chemical class O[C@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-WAXACMCWSA-N 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 239000000043 antiallergic agent Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 235000005300 cardamomo Nutrition 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 229940101029 dipotassium glycyrrhizinate Drugs 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 230000037336 dry skin Effects 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 230000005670 electromagnetic radiation Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 239000003256 environmental substance Substances 0.000 description 1
- DZGCGKFAPXFTNM-UHFFFAOYSA-N ethanol;hydron;chloride Chemical compound Cl.CCO DZGCGKFAPXFTNM-UHFFFAOYSA-N 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 210000002683 foot Anatomy 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 238000009413 insulation Methods 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 238000010422 painting Methods 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 206010036067 polydipsia Diseases 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 230000002028 premature Effects 0.000 description 1
- 206010036596 premature ejaculation Diseases 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000036620 skin dryness Effects 0.000 description 1
- 229940010747 sodium hyaluronate Drugs 0.000 description 1
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 208000009056 telangiectasis Diseases 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/02—Algae
- A61K36/05—Chlorophycota or chlorophyta (green algae), e.g. Chlorella
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
- A61K36/638—Ligustrum, e.g. Chinese privet
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9062—Alpinia, e.g. red ginger or galangal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/06—Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/31—Hydrocarbons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
- A61K8/4946—Imidazoles or their condensed derivatives, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/673—Vitamin B group
- A61K8/675—Vitamin B3 or vitamin B3 active, e.g. nicotinamide, nicotinic acid, nicotinyl aldehyde
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/678—Tocopherol, i.e. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/89—Polysiloxanes
- A61K8/891—Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/005—Preparations for sensitive skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/805—Corresponding aspects not provided for by any of codes A61K2800/81 - A61K2800/95
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Chemical & Material Sciences (AREA)
- Mycology (AREA)
- Alternative & Traditional Medicine (AREA)
- Medical Informatics (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Dermatology (AREA)
- Dispersion Chemistry (AREA)
- Medicines Containing Plant Substances (AREA)
- Cosmetics (AREA)
Abstract
本发明公开了一种具有抗敏止痒功效的护肤组合物,由A相、B相和C相组成;所述A相由下述重量百分比原料组成:辛酸/癸酸甘油三酯1.00~6.00wt%、聚二甲基硅氧烷1.00~3.00wt%、角鲨烷1.00~4.00wt%、生育酚乙酸酯0.10~2.00wt%、甘油硬脂酸酯/PEG‑100硬脂酸酯2.00~6.00wt%;所述B相由下述重量百分比原料组成:甘油3.00~10.00wt%、黄原胶0.01~1.00wt%、尿囊素0.10~1.00wt%、EDTA二钠0.01~0.10wt%、烟酰胺0.10~3.00wt%、水余量;所述C相由下述重量百分比原料组成:中药提取物0.50~3.00wt%、防腐剂0.05~0.20wt%;所述中药提取物由下述重量份配比的原料药制成:覆盆子40~70、女贞子20~40、雨生红球藻10~40、红豆蔻30~50、樱花10~20。本发明具有很好的抗敏止痒效果及祛除面部红血丝的功效。
Description
技术领域
本发明涉及一种护肤组合物,具体地说是一种具有抗敏止痒功效的护肤组合物、乳液及其制备方法。
背景技术
环境的变化影响人类的衣食住行与人类的健康。我们生活的外部环境中存在多种影响皮肤健康的因素,如我们熟悉的紫外线、电磁辐射、雾霾、酸雨、环境化学物质等。危害因素可以引起皮肤的诸多问题,最常见的是皮肤干燥、过敏、瘙痒等。此外,随着年龄增加,皮肤也随之老化,其角质层内的天然保湿因子含量降低,脂质水平下降,使皮肤保存水分的能力下降,引起角质层内含水量降低,免疫力降低,同样导致皮肤干燥、过敏和瘙痒等问题。为了保护皮肤免受外界侵害,研究如何有效安全的进行皮肤过敏防护及有效减轻或治愈皮肤瘙痒等症状正在成为健康护理领域研究的热点之一。
目前市场中低敏、低刺激护肤品极受消费者追捧。此类产品均是选择刺激性较弱的原料,但是如何有效的增加皮肤的抵抗力从根本解决皮肤过敏问题,缓解或避免因皮肤干躁、过敏或其他原因引起的皮肤瘙痒不适症状是本领域技术人员研究的重点。
另外,有很多使用者面部皮肤角质层薄弱导致毛细血管位置更容易接触和感知到外界环境变化,从而造成毛细血管扩展而引起的面部红血丝症状,此类使用者选择护肤品更要慎重。如何帮助红血丝患者抵御外界刺激,减轻或去除面部红血丝症状也是本领域亟待解决的技术问题。
发明内容
本发明的首要目的在于提出一种具有抗敏止痒功效的护肤组合物。
本发明的再一目的在于提出一种上述护肤组合物的制备方法及得到护肤乳液。
本发明的发明思路为:
本发明利用先进的生物技术,结合中国传统的中医理论,将覆盆子、女贞子、雨生红球藻、红豆蔻和樱花有效的组合在一起,形成复方,并将其作为活性组分,制备成护肤制剂,其具有抑制皮肤过敏,缓解皮肤瘙痒及有效减轻皮肤红血丝的功效。
覆盆子:性味甘、酸,性温。归肝、肾、膀胱经。具有益肾固精缩尿、养肝明目的功效。主治:遗精滑精,遗尿尿频,阳痿早泄,目暗昏花。
女贞子:性味甘、苦,凉。归肝、肾经。具有补益肝肾、明目和清虚热的功效。主治头晕目眩,须发早白,视物昏花及阴虚发热。
雨生红球藻:又称湖生红球藻或湖生血球藻,是一种普遍存在的绿藻,属于团藻目,红球藻科。我们现在知道这种藻在适宜它生长的条件下广泛存在于自然界中。
红豆蔻:性味辛,温。归脾、肺经。具有散寒燥湿和醒脾消食的功效。主要用于脘腹冷痛、食积胀满、呕吐泄泻及饮酒过多。
樱花:具有很好的收缩毛孔和平衡油脂的功效,含有丰富的天然维生素A、B、E,樱叶黄酮还具有美容养颜、促进糖分代谢的药效。樱花品种相当繁多,数目超过三百种以上,全世界共有野生樱花约150种,中国有50多种。本发明对樱花品种无限制。
为实现本发明的目的,本发明采用如下具体技术方案:
一种具有抗敏止痒功效的护肤组合物,其中,所述护肤组合物由A相、B相和C相组成;其中,
所述A相由下述重量百分比原料组成:
所述B相由下述重量百分比原料组成:
所述C相由下述重量百分比原料组成:
中药提取物 0.50~3.00wt%
防腐剂 0.05~0.20wt%;
所述中药提取物由下述重量份配比的原料药制成:
覆盆子40~70、女贞子20~40、雨生红球藻10~40、红豆蔻30~50、樱花10~20。
所述中药提取物的制备方法为:
(1)按照上述重量份配比称取原料药并粉碎至60~80目;
(2)用体积百分比为60%~95%乙醇提取,原料药与乙醇质量体积比g/mL为1:10~1:20,50℃~70℃提取1~2小时得提取液;
(3)将步骤(2)得到的提取液冷却至室温,80~120目过滤,得滤液;
(4)将滤液旋转蒸发乙醇浓缩至生药浓度为0.2~0.5g/mL,得浓缩物;
(5)浓缩物中加入原始乙醇量的1,3-丁二醇混溶均匀,真空抽滤,收集滤液即得。
所述步骤(2)中乙醇的体积百分比为70%,原料药与乙醇质量体积比g/ml为1:15。
所述步骤(5)中真空抽滤条件为在布氏漏斗里铺0.8~1.5μm滤板,进行真空抽滤。
一种上述护肤组合物的制备方法,其中,所述方法步骤如下:
(1)将B相中黄原胶与甘油混合均匀后加入水中,备用;将尿囊素、EDTA二钠、烟酰胺加入上述黄原胶甘油混合物中,搅拌升温至80~95℃,保温搅拌10~40分钟;
(2)依次称取A相原料,混合搅拌升温至80~95℃,保温搅拌10~40分钟;
(3)将步骤(2)原料加入步骤(1)中,搅拌均质5~20分钟;
(4)降温至45℃以下加入C相原料,搅拌均匀,出料。
所述步骤(1)中升温速率为1~2℃/分钟。
所述步骤(2)中升温速率为1~2℃/分钟。
所述步骤(4)中降温速率为1~2℃/分钟。
一种具有抗敏止痒功效的护肤制剂,其中,所述护肤制剂由上述方法制成。
上述的具有抗敏止痒功效的护肤制剂为乳液。
本发明提供的中药组合物采用醇提法进行提取,醇提法为发明人推荐的最佳提取方法。但也可采用其他中药学领域公知的提取方法提取,如水提等,甚至经简单粉碎混合后涂抹皮肤或添加进护肤品基质中也可以起到所述功效,只是功效较醇提稍弱。
本发明所述乳液的推荐使用方法为:洁面后,均匀涂敷于面部即可。
本发明经实验证实对透明质酸酶具有很强的抑制作用,说明具有很好的抗敏功效。同时本发明具有很好的止痒效果。本发明制备成护肤制剂具有很好的祛除面部红血丝的功效。本发明的原材料获取容易、制备方法简便,绿色安全,易于被过敏人群接受,具有很好的应用前景和市场前景。
附图说明
图1为本发明所述中药提取物透明质酸酶抑制率的测定结果图;
图2为人体面部VISIA图像代表图。
具体实施方式
本实施例所用药材均可以从中国药材集团公司购买得到,符合中华人民共和国药典2010版标准。其他原料均可通过市售购买获得,本发明使用原料的来源见表1,本发明所用的仪器名称及厂家见表2。
表1
名称 | 型号 | 厂家 |
恒温水浴锅 | HH·S1-M | 北京长安科学仪器厂 |
高速多功能粉碎机 | JP-400B-8 | 永康市九品工贸有限公司 |
智能控温加热搅拌器 | SZCL | 巩义市予华仪器有限公司 |
旋转蒸发器 | RE-2000 | 上海亚荣生化仪器厂 |
循环水式真空泵 | SHB-Ⅲ | 郑州长城科工贸有限公司 |
表2
实施例1本发明所述乳液的制备
原料及配比(质量百分比),见表3:
表3
中药提取物的制备:
(1)按照下述配比称取原料药,粉碎至60目,混匀;
覆盆子65g、女贞子35g、雨生红球藻40g、红豆蔻50g、樱花20g。
(2)用体积百分比为95%乙醇提取,原料药与乙醇质量体积比g/mL为1:15,70℃加热搅拌提取1小时得提取液;
(3)将步骤(2)得到的提取液冷却至室温,120目过滤,得滤液;
(4)将滤液旋转蒸发乙醇浓缩至生药浓度为0.5g/mL,得浓缩物;
(5)浓缩物中加入原始乙醇量的1,3-丁二醇混溶均匀,在布氏漏斗里铺1.2μm滤板真空抽滤,收集滤液即得。
乳液的制备方法:
(1)将B相中黄原胶与甘油混合均匀后加入水中,备用;将尿囊素、EDTA二钠、烟酰胺加入上述黄原胶甘油混合物中,搅拌升温至80℃,升温速率1℃/mim,保温搅拌20分钟;
(2)依次称取A相原料,混合搅拌升温至80℃,升温速率1℃/mim,保温搅拌20分钟;
(3)将步骤(2)原料加入步骤(1)中,搅拌均质5分钟;
(4)降温至30℃加入C相原料,降温速率1℃/mim,搅拌均匀,出料。
实施例2本发明所述乳液的制备
原料及配比(质量百分比),见表4:
表4
中药提取物的制备:
(1)按照下述配比称取原料药,粉碎至70目,混匀;
覆盆子40g、女贞子20g、雨生红球藻30g、红豆蔻45g、樱花15g。
(2)用体积百分比为70%乙醇提取,原料药与乙醇质量体积比g/mL为1:10,60℃加热搅拌提取1.5小时得提取液;
(3)将步骤(2)得到的提取液冷却至室温,100目过滤,得滤液;
(4)将滤液旋转蒸发乙醇浓缩至生药浓度为0.3g/mL,得浓缩物;
(5)浓缩物中加入原始乙醇量的1,3-丁二醇混溶均匀,在布氏漏斗里铺1.5μm滤板真空抽滤,收集滤液即得。
乳液的制备方法:
(1)将B相中黄原胶与甘油混合均匀后加入水中,备用;将尿囊素、EDTA二钠、烟酰胺加入上述黄原胶甘油混合物中,搅拌升温至95℃,升温速率2℃/mim,保温搅拌10分钟;
(2)依次称取A相原料,混合搅拌升温至95℃,升温速率2℃/mim,保温搅拌10分钟;
(3)将步骤(2)原料加入步骤(1)中,搅拌均质15分钟;
(4)降温至40℃加入C相原料,降温速率2℃/mim,搅拌均匀,出料。
实施例3本发明所述乳液的制备
原料及配比(质量百分比),见表5:
表5
中药提取物的制备:
(1)按照下述配比称取原料药,粉碎至80目,混匀;
覆盆子70g、女贞子40g、雨生红球藻10g、红豆蔻30g、樱花10g。
(2)用体积百分比为60%乙醇提取,原料药与乙醇质量体积比g/mL为1:20,50℃加热搅拌提取2小时得提取液;
(3)将步骤(2)得到的提取液冷却至室温,80目过滤,得滤液;
(4)将滤液旋转蒸发乙醇浓缩至生药浓度为0.2g/mL,得浓缩物;
(5)浓缩物中加入原始乙醇量的1,3-丁二醇混溶均匀,在布氏漏斗里铺0.8μm滤板真空抽滤,收集滤液即得。
乳液的制备方法:
(1)将B相中黄原胶与甘油混合均匀后加入水中,备用;将尿囊素、EDTA二钠、烟酰胺加入上述黄原胶甘油混合物中,搅拌升温至90℃,升温速率1℃/mim,保温搅拌40分钟;
(2)依次称取A相原料,混合搅拌升温至90℃,升温速率2℃/mim,保温搅拌40分钟;
(3)将步骤(2)原料加入步骤(1)中,搅拌均质20分钟;
(4)降温至45℃加入C相原料,降温速率1℃/mim,搅拌均匀,出料。
本发明功效实验
一、抗过敏性功效
1、实验原理
本方法采用透明质酸酶体外抑制法测定化妆品原料及化妆品产品的抗过敏功效。透明质酸酶是过敏反应的参与者,分解体内的透明质酸(HA),使其变成低分子量的酸性刺激源,引起组胺释放,诱导机体产生敏感症状,研究表明透明质酸酶与炎症、过敏有强相关性,许多抗过敏药物有强抑制透明质酸酶活性的作用。透明质酸酶能够不加选择地水解透明质酸中的β-N-乙酰葡糖胺与D-葡糖醛酸盐之间的1,4键,而得到β-N-乙酰葡糖胺,β-N-乙酰葡糖胺在碱性条件下可以与乙酰丙酮缩合生成生色原2-甲基-3-二乙酰吡咯衍生物,生色原与对-二甲氨基苯甲醛在浓盐酸乙醇中生色。
2、实验内容
采用透明质酸酶体外抑制实验Elson-Morgan法进行。取0.1mL 0.25mmol/L CaCl2溶液和0.5mL透明质酸酶液37℃保温培养20min;加入实施例1制备中药提取物0.5mL,继续37℃保温培养20min;加入0.5mL透明质酸钠液37℃保温30min,常温放置5min;加入0.1mL0.4mol/L NaOH溶液和0.5mL乙酰丙酮溶液,置于沸水浴中加热15min后立即用冰水进行冷却5min;加入埃尔利希试剂1.0mL并用3.0mL无水乙醇进行稀释,放置20min显色,用分光光度计测定其吸光度值。
抗过敏活性计算公式:
式中:A——对照溶液ABS值(用醋酸缓冲溶液代替样品溶液)
B——对照空白溶液ABS值(用醋酸缓冲溶液代替样品溶液及酶液)
C——试样溶液ABS值
D——试样空白溶液ABS值(用醋酸缓冲溶液代替酶液)
实验时先对A组试样进行450~700nm范围的波长扫描,以确定最大吸收波长,然后以去离子水作为参比,在该最大吸收波长处分别进行ABS值测定。
同一样品的两次测定值之差应不超过两次测定平均值的10%。
3、结果分析
实验所采用样品的透明质酸酶抑制率的测定结果如图1所示,测试浓度为1.0%的水溶液,数据为三次平均值。
分析:其中阳性对照为甘草酸二钾。由图1看出抑制率在有效范围内,实施例1制备中药提取物的抑制率在有效范围内(0~100%),即具有抑制透明质酸酶的功效,且越大效果越好(有效范围0~100%)。实施例1制备提取物透明质酸酶抑制率接近阳性对照。
因此,实施例1制备中药提取物具有抗敏效果。发明人用实施例2、实施例3制备的中药提取物进行相同的实验,得到相同的结论。说明本发明制备的中药提取物具有良好的抗敏效果。
二、止痒功效研究——磷酸组织胺致痒法
1、实验材料
实验动物:豚鼠32只,雌雄各半,350±20g。
受试样品:实施例1制备中药提取物用量:高剂量组为1.0g/Kg;中剂量组为
0.6g/Kg;低剂量组为0.2g/Kg。模型对照组:蒸馏水(1.0g/Kg)。
2、实验方法
a.取豚鼠32只,于实验前1天右后足背剃毛,随机分成4组。即实施例1制备中药提取物高剂量组、中剂量组、低剂量组及模型对照组。
b.连续2天于剃毛处分别均匀涂抹相应剂量样品、模型对照组。
c.实验第3天,精密称取磷酸组胺适量,临用前以蒸馏水配成体积百分比为0.01%、0.02%、0.03%、0.04%……梯度浓度备用。用粗砂纸将豚鼠右后足背剃毛处擦伤,面积约1cm2,局部再涂药1次,于末次涂药10min后在擦伤处滴0.01%磷酸组胺0.05mL,以后每隔3分钟依0.01%、0.02%、0.03%、0.04%……递增浓度,每次均为0.05mL。直到出现豚鼠回头舔右后足,以最后出现豚鼠回头舔右后足时所滴取的磷酸组胺总量平均值为致痒阈。
d.计算各组致痒阈并比较组间的差异性。
表6豚鼠磷酸组胺致痒反应的影响(x±s,n=6)
注:与模型对照组比较,*p<0.05
由上表可知,与模型组相比较,样品组对豚鼠磷酸组胺致痒反应有显著的抑制作用(P<0.05)。因此,实施例1制备中药提取物具有很好的止痒效果。发明人用实施例2、实施例3制备的中药提取物及实施例1至3制备的乳液进行相同的实验,得到相同的结论。说明本发明制备的中药提取物及乳液具有良好的止痒功效。
三、本发明制备的乳液祛除红血丝功效评价实验
面部红血丝,医学上又称为面部毛细血管扩张,是由于面部毛细血管壁的弹性降低,脆性增强,血管持续性、不均匀的扩张甚至破裂引起。
1.实验方法
(1)实验原理:采用人体面部VISIA图像分析样品对受试者面部红血丝的影响来判断样品祛除红血丝功效。
(2)实验样品:实施例1制备乳液
(3)实验人群及测试时间:选择有红血丝症状者30名,受试部位有明显红血丝症状,受试期间不涂抹任何与实验无关的药物或者化妆品。
(4)涂抹方式:全脸涂抹,每天早晚各一次。观察对比受试者四周前后的面部VISIA图像。
2.实验结果
经过具有皮肤临床评价经验的专业人士对受试者使用实施例1制备乳液四周前后面部红血丝去除情况的观察和分析,得到结果如表7所示。
评判标准:
明显去除(有效):治疗面有70%无红血丝、无痛痒、弹性良好、皮肤颜色基本正常,部分皮肤外表与正常皮肤稍有不同。
去除(有效):治疗面有50%无红血丝、无痛痒、弹性良好、皮肤颜色基本正常,部分皮肤外表与正常皮肤稍有不同。
无效:治疗面有80%以上仍然有明显红血丝症状,颜色深浅不一或者皮肤发暗,有瘙痒感。
表7
由表7可以看出,针对面部红血丝症状,有效率达到80%,其中明显去除10例,占有效率的42%。
图2为人体面部VISIA图像代表图,如图2所示,受试者在使用实施例1制备乳液四周后(右图)面部红血丝(方框所选区域)均明显变淡(左图为涂抹前),肤色变均匀。说明实施例1制备乳液具有改善皮肤微循环,去红血丝的作用。
发明人用实施例2及3制备乳液同样做上述试验,结果同实施例1。说明本发明具有良好的去除面部红血丝、改善肌肤微循环的功效。
Claims (10)
1.一种具有抗敏止痒功效的护肤组合物,其特征在于,所述护肤组合物由A相、B相和C相组成;其中,
所述A相由下述重量百分比原料组成:
所述B相由下述重量百分比原料组成:
所述C相由下述重量百分比原料组成:
中药提取物 0.50~3.00wt%
防腐剂 0.05~0.20wt%;
所述中药提取物由下述重量份配比的原料药制成:
覆盆子40~70、女贞子20~40、雨生红球藻10~40、红豆蔻30~50、樱花10~20。
2.如权利要求1所述的护肤组合物,其特征在于,所述中药提取物的制备方法为:
(1)按照权利要求1所述重量份配比称取原料药并粉碎至60~80目;
(2)用体积百分比为60%~95%乙醇提取,原料药与乙醇质量体积比g/mL为1:10~1:20,50℃~70℃提取1~2小时得提取液;
(3)将步骤(2)得到的提取液冷却至室温,80~120目过滤,得滤液;
(4)将滤液旋转蒸发乙醇浓缩至生药浓度为0.2~0.5g/mL,得浓缩物;
(5)浓缩物中加入原始乙醇量的1,3-丁二醇混溶均匀,真空抽滤,收集滤液即得。
3.如权利要求2所述的护肤组合物,其特征在于,所述步骤(2)中乙醇的体积百分比为70%,原料药与乙醇质量体积比g/ml为1:15。
4.如权利要求2所述的护肤组合物,其特征在于,所述步骤(5)中真空抽滤条件为在布氏漏斗里铺0.8~1.5μm滤板,进行真空抽滤。
5.一种权利要求1至4中任意一项所述护肤组合物的制备方法,其特征在于,所述方法步骤如下:
(1)将B相中黄原胶与甘油混合均匀后加入水中,备用;将尿囊素、EDTA二钠、烟酰胺加入上述黄原胶甘油混合物中,搅拌升温至80~95℃,保温搅拌10~40分钟;
(2)依次称取A相原料,混合搅拌升温至80~95℃,保温搅拌10~40分钟;
(3)将步骤(2)原料加入步骤(1)中,搅拌均质5~20分钟;
(4)降温至30~45℃加入C相原料,搅拌均匀,出料。
6.如权利要求5所述的制备方法,其特征在于,所述步骤(1)中升温速率为1~2℃/分钟。
7.如权利要求5所述的制备方法,其特征在于,所述步骤(2)中升温速率为1~2℃/分钟。
8.如权利要求5所述的制备方法,其特征在于,所述步骤(4)中降温速率为1~2℃/分钟。
9.一种具有抗敏止痒功效的护肤制剂,其特征在于,所述护肤制剂由权利要求5所述方法制成。
10.如权利要求9所述的具有抗敏止痒功效的护肤制剂,其特征在于,所述护肤制剂为乳液。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610640817.4A CN106166123B (zh) | 2016-08-06 | 2016-08-06 | 具有抗敏止痒功效的护肤组合物、乳液及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610640817.4A CN106166123B (zh) | 2016-08-06 | 2016-08-06 | 具有抗敏止痒功效的护肤组合物、乳液及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN106166123A CN106166123A (zh) | 2016-11-30 |
CN106166123B true CN106166123B (zh) | 2018-12-25 |
Family
ID=58064674
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610640817.4A Active CN106166123B (zh) | 2016-08-06 | 2016-08-06 | 具有抗敏止痒功效的护肤组合物、乳液及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106166123B (zh) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106963670B (zh) * | 2017-04-19 | 2021-03-23 | 北京赛尔佳人化妆品有限公司 | 一种海藻保湿面膜液及其制备方法 |
CN113509409B (zh) * | 2021-07-26 | 2022-06-21 | 中国科学院西双版纳热带植物园 | 一种红豆蔻花精油的制备方法及其应用 |
CN118021647B (zh) * | 2024-04-10 | 2024-06-11 | 云南慎言生物科技有限公司 | 一种含水蛭素的美容护肤面膜及其制备方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104188858A (zh) * | 2014-08-26 | 2014-12-10 | 沈华辉 | 一种具有抗皱、美白、祛痘、祛疤痕的化妆品组合物及其制造方法 |
CN104490715A (zh) * | 2015-01-08 | 2015-04-08 | 上海圣婕化妆品有限公司 | 一种含有异构寡糖的抗敏舒缓面膜精华液及其制备方法 |
-
2016
- 2016-08-06 CN CN201610640817.4A patent/CN106166123B/zh active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104188858A (zh) * | 2014-08-26 | 2014-12-10 | 沈华辉 | 一种具有抗皱、美白、祛痘、祛疤痕的化妆品组合物及其制造方法 |
CN104490715A (zh) * | 2015-01-08 | 2015-04-08 | 上海圣婕化妆品有限公司 | 一种含有异构寡糖的抗敏舒缓面膜精华液及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN106166123A (zh) | 2016-11-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN110292552B (zh) | 一种具有抗敏修复功效的复方植物提取物及其制备方法和应用 | |
CN113499290B (zh) | 一种具有舒缓、修护作用的组合物及其制备方法和应用 | |
CN106166123B (zh) | 具有抗敏止痒功效的护肤组合物、乳液及其制备方法 | |
KR20200029981A (ko) | 아토피 예방 또는 개선용 조성물 및 이의 제조방법 | |
CN105998617B (zh) | 一种具有舒缓老年皮肤瘙痒功效的外用中药提取物及制备方法和用途 | |
CN102430035A (zh) | 具有舒敏止痒功效的中药组合物、制剂及其制备方法 | |
CN115487131A (zh) | 一种日用面部皮肤护肤组合物及其制备方法 | |
CN111449985A (zh) | 一种臻效滋润修护免洗面膜及其制备方法 | |
CN109939193A (zh) | 一种治疗皮肤湿疹的组合物,制剂及制备方法和应用 | |
CN105726439A (zh) | 金蝉花美白保湿药妆品及其制备方法 | |
CN103860437A (zh) | 黑蒜提取物面膜及其制备方法 | |
CN104188859B (zh) | 一种含天然成分提取物的抗皱嫩肤乳液及其制备方法 | |
CN110801412B (zh) | 一种皮脂仿生组合物及其应用和化妆品 | |
KR20160146021A (ko) | 병풀추출물, 목련수피 추출물, 나한백가지 추출물, 유칼립투스잎오일, 보리지씨오일을 유효성분으로 하는 피부진정 및 아토피 개선용 화장료 조성물 | |
CN111973511A (zh) | 一种保湿组合物及护肤品 | |
CN115177562B (zh) | 具有抗敏舒缓功效的植物复合发酵原浆的制备方法和应用 | |
CN109010220B (zh) | 一种化妆品组合物及其制备方法 | |
CN110974775A (zh) | 一种含葛仙米的舒敏组合物及其制备方法和应用 | |
CN107049866B (zh) | 一种抗过敏植物组合物及其应用 | |
CN104983642A (zh) | 具有护肤功效的外用中药组合物、护肤制剂及其制备方法 | |
CN106166256B (zh) | 具有抗敏止痒功效的外用中药组合物、制剂及其制备方法 | |
CN110141542B (zh) | 一种含太子参的舒敏剂及其制备方法 | |
CN111202821B (zh) | 具有舒敏抗炎功效的中药提取物及其制备方法与应用 | |
CN115089648A (zh) | 一种用于预防/治疗痔疮的卫生湿巾及其制备方法 | |
CN108014037B (zh) | 一种滋养润肤霜及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20231219 Address after: Room C0409, 4th Floor, Science and Technology Complex Building, No. 7 Beinong Road, Huilongguan Town, Changping District, Beijing 102208 (Changping Demonstration Park) Patentee after: Beijing Weiye Innovation Technology Co.,Ltd. Address before: Room 1405, Building 2, Yard 1, Shangdi 10th Street, Haidian District, Beijing, 100085 Patentee before: BEIJING GUOJI ZHONGFANG TRADITIONAL CHINESE MEDICINE Research Institute |
|
TR01 | Transfer of patent right |